Product Name | SARS - CoV T - cell Peptide Antigens SetNEW |
Size | 0.25 mg NET peptide |
Catalog # | AS-65633 |
US$ | $372 |
The SARS-CoV T-cell peptide antigens set contains 5 peptides corresponding to SARS-CoV spike protein sequence. The sequences have been tested for HLA binding with SARS-CoV protein and includes a positive and a negative control. CV1, CV2 and CV3 sequences are also seen within the spike glycoprotein of SARS-CoV2. The peptide sequences are offered in net peptide quantities in individual vials of 0.25 mg each. The peptide epitopes can be used in ELISPOT, cytokine and CTL assays. The sequences in the set are,CV1-VLNDILSRL CV2-NLNESLIDL CV3-FIAGLIAIV CV4-KLPDDFMGCV (+ve control) CV5-AYRPPNAPIL (-ve control) | |
Detailed Information | DatasheetMaterial Safety Data Sheets (MSDS) |
Storage | -20°C |
References | 1. Lv Y, et al. Identification of a novel conserved HLA-A*0201-restricted epitope from the spike protein of SARS-CoV. BMC immunology.2009 Dec 1;10(1):61.2. Ahmed SF et al. Preliminary identification of potential vaccine targetsfor the COVID-19 coronavirus (SARS-CoV-2) based on SARS-CoV immunologicalstudies. Viruses. 2020 Mar;12(3):254. |